Chemotherapy's hidden toll on blood vessels revealed

NCT ID NCT03062878

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at how anthracycline-based chemotherapy affects blood vessel health and blood pressure control in 60 people with breast cancer or lymphoma. Researchers measured artery stiffness, blood flow, and skin blood vessel responses. The goal is to understand why cancer survivors face higher heart disease risk and find ways to reduce it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors understand how chemotherapy harms blood vessels, leading to better ways to protect heart health in cancer survivors.

What could go wrong

This is an observational study, not a treatment trial. It only measures changes and does not test any new therapy, so it cannot directly improve patient outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm chemotherapy-induced toxicity lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lafene Health Center

    Manhattan, Kansas, 66502, United States